This interview is in a media partnership with the German startup association. Their German Startup Awards (GSA21) honor each year outstanding female and male founders and investors in special categories.

The 2021 award goes to Finn Hänsel, founder of Sanity Group. They are looking to utilize the components of cannabis in medicine to make new treatments available e.g. psychological disorders.

They are looking to build a new kind of pharma company, based on cannabis: All over the world, scientific discoveries and their medical potential are redefining the way society, politics and the medical community think about Cannabis as a plant.

Our team looks back on a strong track record in building and scaling companies in various industries, creating hundreds of jobs and millions in shareholder value in the process. Being joined by renowned industry leaders and medical experts, Sanity Group continuously positions itself on the brink of innovation and is equipped to shape the Cannabis industry in Europe.

We provide a unique community of industry experts, excellent talent, operational backing, and capital to our fast-growing portfolio of ventures.

Finn is also a mentor at TechStars' Berlin-based accelerator program.